Latest from Kromek

Innovate UK provides funds for two projects to advance low-dose molecular breast imaging solution.

Kromek Group plc (AIM: KMK), a leading developer of radiation and bio-detection technology solutions for the advanced imaging and CBRN detection segments, announces its interim results for the six months ended 31 October 2022.

Kromek Group plc had secured a repeat order from a US government customer for its wearable D3S ID Nuclear Radiation Detector.

Kromek Group is pleased to announce that it has entered into a distribution agreement with Smiths Detection, a global leader in threat detection and security screening technologies. A significant expansion of agreement to include distribution of Kromek’s radiation detection solutions in the Middle East and certain markets in Asia and Australasia

Kromek wins two contracts totalling £1.5m for the supply of our D3M and D3S-based products for European government end-user.

Kromek, last month celebrated a significant UK Government Department order and hosted Col. Vityalii Kraskovskyi, the Defence Attaché of Ukraine, at the Counter Threat Symposium 2022 held at the Farnborough International Exhibition and Conference Centre.